Wednesday's After-Hours Movers

By: via Benzinga
Biodel Inc(NASDAQ: BIOD) +27% - Reported positive preliminary results from Phase 2a clinical trial of BIOD-531. BIND ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.